Earnings from Rexnord Corporation [RXN] are scheduled on April 27, 2021, after the market closes. It is expected that the company will report weak earnings for the quarter ending Mar 2021.
RXN Stock Earnings Outlook For The Current Quarter
The consensus estimates for the quarter suggest that the company would earn $0.45 per share on revenue of $532.46M. Taking a look at the future, the company is projected to report revenue of $526.41M at an earnings per share of $0.5 for the Jun 2021 quarter. The estimates represent year-over-year improvements of 5.70% in revenue and 15.81% in earnings per share for the company.
RXN Stock Earnings Forecast For The Current Year
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
For the full financial year, Rexnord Corporation [NYSE:RXN] is forecasted to generate revenue of $2.14B. The figure is about $160.0 million above what the company actually reported for the fiscal year 2020. In terms of EPS, it is estimated to be $1.95 in 2021, which is $0.18 higher than the figure in FY20. Based on current estimates, earnings are expected to grow 10.20% this year, 15.90% next year, and 10.91% annually over the next five years. With regard to sales, forecasts suggest an incline of 7.90% in current fiscal year and 5.70% over following year.
RXN Stock Price Performance
At a recent check today, Rexnord Corporation [NYSE:RXN] finished down -0.04% at $50.40. The stock’s day high price was $51.52, and its lowest was $50.38. Its price rose 3.09% in the last five days. Since the beginning of the year, Rexnord Corporation’s shares are up nearly 27.68%. However, the share price is -2.21% below its one year high. The top price reached by the shares of the company was $51.54 on 03/12/21, while the 52-week low came on 02/01/21, when the shares were $37.29. In the past year, shares of the company have risen 102.90%. At 50 days, the moving average achieved is $47.94 while at 200 days, the moving average is $37.90. There were 56607.0 shares traded in the last session, down from 0.45 million in the previous session.
Rexnord Corporation [NYSE:RXN] Stock Valuation Metrics
With a prevailing 12-month PE ratio of 42.33, Rexnord Corporation [RXN] does not qualify as a good candidate for the list of underestimated low-priced stocks that should be purchased sooner rather than later. By this measure, the company’s stock is trading at a premium to the industry average of 27.31 times trailing earnings. Investors may find it helpful to look at historical price-sales ratios, and in the case of this stock, 3.00 PS value ratio is reported for the last one year of reported earnings. This is above the average return 1.57 for the industry, which means RXN offers an unattractive investment opportunity than its competitors do.
RXN Share Price Support And Resistance Levels
Based on the daily chart, the immediate backing lies around the 50.41 level, and the violation of this level will cause a further drop to 50.03 level. At the upper end, 52.31 remains a key resistance. As the stock increases, it may find resistance at 51.91. In the 14-day chart, the Relative Strength Index standing at 61.71 suggests a technical neutral stance while the MACD standing at 1.29 indicates price will increase in the next trading period. Stochastic %K at 80.05% suggests selling the stock while Percent R indicator at 26.77% suggests bullish price movement.
How do analysts view Rexnord Corporation?
In regard to the share price forecast for Rexnord Corporation stock, the analysts, as surveyed by FactSet, forecast the price to reach $54.00 in the next twelve months, representing almost an 6.67% growth from its recent price of $50.40. Among Rexnord Corporation stock projections, $60.00 is the highest analyst target for the stock, while $53.00 is the lowest. Despite this, 8 analysts who share their consensus rating for RXN in 2021 agree that the stock is an Overweight. The latest rating change took place on 2/17/21, when KeyBanc Ratings upgraded the stock from “Sector Weight” to “Overweight.”